Liraglutide 3.0 emg efficacy and safety by baseline BMI in the SCALE Diabetes trial: post-hoc analysis

被引：0
|
作者：
Hemmingsson, J. Udden [1 ]
Rosenstock, J. [2 ]
Davies, M. [3 ]
Bays, H. [4 ]
Cancino, A. -P. [5 ]
Skjoth, T. V. [5 ]
Aroda, V. [6 ]
机构：
[1] Capio St Gorans Hosp, Stockholm, Sweden
[2] Diabet & Endocrine Ctr, Dallas, TX USA
[3] Univ Leicester, Leicester LE1 7RH, Leics, England
[4] L MARC Res Ctr, Louisville, KY USA
[5] Novo Nordisk, Soborg, Denmark
[6] MedStar Hlth Res Inst, Hyattsville, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
646
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [1] Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m2: A Post-hoc Analysis
    le Roux, Carel
    Aroda, Vanita
    Hemmingsson, Joanna
    Cancino, Ana Paula
    Christensen, Rune
    Pi-Sunyer, Xavier
    OBESITY FACTS, 2017, 10 (06) : 531 - 544
  • [2] Comparable efficacy and safety of liraglutide 3.0 mg for weight management across baseline BMI subgroups: results from the SCALE obesity and prediabetes trial
    Madsbad, S.
    Lieberman, G.
    Skjoth, T. V.
    Lilleore, S. K.
    DeFronzo, R. A.
    DIABETOLOGIA, 2016, 59 : S40 - S41
  • [3] Liraglutide 3.0 mg efficacy and safety are similar across baseline Edmonton Obesity Staging System (EOSS) categories: post hoc analysis
    Finer, Nick
    Padwal, Raj
    Kushner, Robert
    Svendson, Claus Bo
    Sharma, Arya
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 8 - 8
  • [4] The efficacy and safety of liraglutide 3.0mg for weight management are similar across baseline Edmonton Obesity Staging System (EOSS) categories: post-hoc analysis at 56 weeks
    Wilding, J. P. H.
    Sharma, A. M.
    Finer, N.
    Padwal, R. S.
    Skjoth, T.
    Jensen, C. B.
    Kushner, R.
    DIABETIC MEDICINE, 2017, 34 : 57 - 57
  • [5] Efficacy and safety of dronedarone by duration of atrial fibrillation history: a post-hoc analysis of the ATHENA trial
    Blomstrom-Lundqvist, C.
    Marrouche, N.
    Connolly, S.
    Genti, V. Corp Dit
    Wieloch, M.
    Koren, A.
    Hohnloser, S. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2988 - 2988
  • [6] Post-Hoc Analysis of Efficacy and Safety in the SWOG S0777 Trial Stratified By Age
    Durie, Brian G. M.
    Lam, Annette
    Ngo, Mai
    Pei, Huiling
    Ammann, Eric M.
    BLOOD, 2022, 140 : 10009 - 10010
  • [7] Efficacy and safety of apixaban for primary prevention in gastrointestinal cancers: A post-hoc analysis of the AVERT trial
    Ladha, Danyal
    Mallick, Ranjeeta
    Wang, Tzu-Fei
    Caiano, Lucia
    Wells, Philip S.
    Carrier, Marc
    THROMBOSIS RESEARCH, 2021, 202 : 151 - 154
  • [8] Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type2 diabetes mellitus: A post-hoc analysis of a phase3 randomized clinical trial
    Kaneko, Shizuka
    Nishijima, Keiji
    Bosch-Traberg, Heidrun
    Kaku, Kohei
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 840 - 849
  • [9] Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial
    Robert A. Wise
    Benjamin M. Scirica
    Deepak L. Bhatt
    Sami Z. Daoud
    Ferran Chuecos
    Esther Garcia Gil
    Kenneth R. Chapman
    Advances in Therapy, 2021, 38 : 5381 - 5397
  • [10] Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial
    Wise, Robert A.
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Daoud, Sami Z.
    Chuecos, Ferran
    Gil, Esther Garcia
    Chapman, Kenneth R.
    ADVANCES IN THERAPY, 2021, 38 (10) : 5381 - 5397
12345